Bass returns funds but vows to continue pharma fight
24-02-2016
Celgene fends off Kyle Bass challenge
17-11-2015
relif / Shutterstock.com
The Coalition for Affordable Drugs and Anacor Pharmaceuticals will face off in a dispute over the validity of two anti-fungal patents after the Patent Trial and Appeal Board (PTAB) gave the go-ahead to two inter partes review petitions.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
PTAB; USPTO; IPR; Anacor Pharmaceuticals; Kyle Bass;
